SCHEMBL8779031

SCHEMBL8779031

O=C1c2cccc(Cl)c2CCC12CCCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.40
HTR2A P28223 5/20 0.40
HTR2C P28335 5/20 0.40
HTR2B P41595 5/20 0.40
DRD2 P14416 5/20 0.38
KDM1A O60341 1/20 0.37
PDE7A Q13946 2/20 0.36
MAPT P10636 2/20 0.36
NSD2 O96028 1/20 0.35
BCHE P06276 1/20 0.35
DAO P14920 1/20 0.35
CES1 P23141 1/20 0.35
GRIN1 Q05586 3/20 0.35
GRIN2A Q12879 3/20 0.35
SLC6A4 P31645 2/20 0.35
GRIN2D O15399 2/20 0.35
GRIN3B O60391 2/20 0.35
GRIN2B Q13224 2/20 0.35
GRIN2C Q14957 2/20 0.35
GRIN3A Q8TCU5 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30842141 0.80 PARP10 (0.46) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL8779060 0.80 KDM1A (0.37) HTR2AHTR2CKDM1APDE7ABCHE
SCHEMBL8778968 0.77 MEN1 (0.36) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL8779106 0.73 SIGMAR1 (0.40) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL31546232 0.72 PARP10 (0.49) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL8778970 0.72 SIGMAR1 (0.70) SIGMAR1HTR2AHTR2CHTR2BDRD2
Hydrochloric Acid SCHEMBL22493661 0.71 MAPT (0.37) SIGMAR1HTR2CHTR2BDRD2KDM1A
Hydrochloric Acid SCHEMBL31288523 0.71 MAPT (0.37) SIGMAR1HTR2CHTR2BDRD2KDM1A
SCHEMBL7500484 0.70 SIGMAR1 (0.68) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL8779044 0.70 HTT (0.52) SIGMAR1HTR2AHTR2CHTR2BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed